Lv11
28 积分 2022-03-02 加入
The mechanism of EZH2/H3K27me3 downregulating CXCL10 to affect CD8+ T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia
5小时前
已完结
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis
5小时前
已完结
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
2天前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
2天前
已完结
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
6天前
已完结
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study
14天前
已完结
SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21
1个月前
已完结
Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment
1个月前
已完结
Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China
1个月前
已完结
The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape
1个月前
已完结